Dr. Rohit Upadhyay, main hub of his studies was exploration of molecular markers for the early diagnosis and prognosis of above-mentioned cancers. During his PhD he worked on susceptibility and prognosis of esophageal and Gastric cancers. He also looked for the functional relevance of these molecular markers. While, his first postdoctoral training he studied genetics of RNA binding proteins and their impact on prognosis of Breast cancer patients. He was project coordinator and co-investigator in a project at department of biological sciences, University of South Carolina, USA. His research work in Weill Cornell Medicine included studying genetics and pharmacology of type 2 Diabetes (metabolic complex disorder) and exploration of genetic/epigenetic biomarkers so that population could be screened for these biomarkers and in future preventive medicines could be tailored for type 2 Diabetes in particular population.
His main current research interest in WCMC-Q is studying genetics of Diabetes (metabolic complex disorder) and exploration of biomarkers for diabetes so that population could be screened for these biomarkers and in future some preventive medicines could be tailored for Diabetes. He involved in many diabetes related projects: 1) Role of miRs in eNOS signaling and effect of metformin 2) Genetic susceptibility of type 2 diabetes/diabetic retinopathy in Qatari population 3) Mechanism of metformin transportation in normal (endothelial), cancerous cell lines and in different organs of mice model of type-2 diabetes. Genetics and cellular mechanisms of complex disorders.